Skip to main content
Premium Trial:

Request an Annual Quote

Beckman to Buy Dako's Flow Cytometry Business

NEW YORK (GenomeWeb News) – Beckman Coulter today said it will buy the flow cytometry business of Dako for an undisclosed sum.
 
Included in the acquisition are Dako’s MoFlo XDP cell sorter and the CyAn research flow cytometer.
 
Beckman President and CEO Scott Garrett said the addition of these tools and assets to its flow cytometry line allows it to offer “a more comprehensive range of research solutions to our customers.”
 
Dako’s flow cytometry arm employs nearly 200 people, including research, sales and marketing, manufacturing, and administrative staffers.
 
The transaction is expected to close by the end of the year.
 
Patrik Dahlen, Dako’s CEO, said selling the flow cytometry business to Beckman Coulter “reinforces our strategic intent to create a more focused business in anatomic pathology and tissue-based cancer diagnostics."

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.